1312471-21-8

Basic information

• Product Name: 2-phenyl-4-isopropylpyridine
• Synonyms: 2-phenyl-4-isopropylpyridine
• CAS NO: 1312471-21-8
• Molecular Weight: 197.28
• Mol File: 1312471-21-8.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 2-phenyl-4-isopropylpyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-phenyl-4-isopropylpyridine(1312471-21-8)
• EPA Substance Registry System: 2-phenyl-4-isopropylpyridine(1312471-21-8)

Safety Data

• Hazardous Substances Data: 1312471-21-8(Hazardous Substances Data)

Upstream product

• 1008-89-5 2-phenylpyridine 
• 1539-32-8 4-isopropyl-2,6-dimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid diethyl ester 
• 1086381-43-2 2-bromo-4-isopropylpyridine 
• 98-80-6 phenylboronic acid 
• 1414972-01-2 2-phenyl-4-(prop-1-en-2-yl)pyridine 
• 57311-18-9 4-chloro-2-phenyl-pyridine 
• 26452-80-2 2,4-dichloropyridine 

Relevant articles and documents

Functionalization of Pyridinium Derivatives with 1,4-Dihydropyridines Enabled by Photoinduced Charge Transfer

By exploiting electron donor-acceptor (EDA) complexes between 1,4-dihydropyridines and N-amidopyridinium salts under visible light irradiation, we discovered that photoinduced intermolecular charge transfer induces a single-electron transfer event without requiring a photocatalyst for the facile functionalization of pyridines. The generality of this method is amenable to various types of 1,4-dihydropyridines radical precursors to generate structurally different radicals such as alkyl, acyl, and carbamoyl radicals, ultimately providing facile access to synthetically valuable C4-functionalized pyridines. A broad range of functional groups are well accommodated under mild and metal-free conditions, and the synthetic utility of the present method is showcased by the late-stage functionalization of a variety of biologically relevant pyridine-based compounds, pharmaceuticals, and peptide feedstocks.

THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF

The invention provides a compound of formula: or a salt thereof, wherein the variables RAA, n, ring A, ring B, R1a, R1b, R2, R3, R4, R5, R6, R7, R8, and R9 have the meaning as described herein, and compositions containing such compounds and methods for using such compounds and compositions.

HETEROLEPTIC IRIDIUM COMPLEXES AS DOPANTS

Novel phosphorescent heteroleptic iridium complexes with phenylpyridine and dibenzo-containing ligands are provided. Alkyl substitution at specific positions on the ligands gives rise to compounds with improved OLED properties, including saturated green emission.